SCHEMBL370091

SCHEMBL370091

Cc1ccc(-c2ccccc2P2C(C)(C)CC3(CC2(C)C)OCCO3)c(N)c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24535255 0.84
SCHEMBL10177371 0.83 MEN1 (0.31)
SCHEMBL370092 0.78 ALDH1A1 (0.32)
SCHEMBL352021 0.76 TSHR (0.33)
SCHEMBL351419 0.74 KDM4E (0.33)
SCHEMBL350079 0.74 NSD2 (0.32)
SCHEMBL10177366 0.74 SMN1; SMN2 (0.34)
SCHEMBL10177367 0.74 NSD2 (0.36)
SCHEMBL408863 0.70 S1PR1 (0.33)
SCHEMBL352304 0.70 HTR7 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593226-B1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS ABBVIE IRELAND UNLIMITED CO (IE) 2018-11-14 EP disclosed
EP-2887941-A1 PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS AbbVie Inc. (US) 2015-07-01 EP disclosed
WO-2014031791-A1 PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS ABBVIE INC. (US) 2014-02-27 WO disclosed
EP-2593439-A2 PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS Abbvie Inc. (US) 2013-05-22 EP disclosed
WO-2012009699-A2 PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2012-01-19 WO disclosed